Evidence map›Paper›PMID 18377703›Full record

ArticleThe international journal of neuropsychopharmacology2008

Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.

Yuri A Blednov, R Adron Harris

Open access · bronzeAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 124 citations in OpenAlex.

  1. Trial
  2. An open-label naturalistic pilot study of acamprosate in youth with autistic disorder.Journal of child and adolescent psychopharmacology · 2011
    Trial
  3. Review
  4. Article
  5. GPCR drug discovery: new agents, targets and indications.Nature reviews. Drug discovery · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Substance Use and Addiction.Advances in neurobiology · 2024
    Review
  10. Review
  11. FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION.Neuroscience and biobehavioral reviews · 2022
    Review
  12. Article
  13. The Role of the Central Amygdala in Alcohol Dependence.Cold Spring Harbor perspectives in medicine · 2021
    Review
  14. Article
  15. Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yuri A BlednovWaggoner Center for Alcohol and Addiction Research, University of Texas, Austin, TX, USA. yablednov@mail.utexas.edu
R Adron Harris
The University of Texas at Austin · US

Funding

INIA: ANIMAL COREU01AA013520 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI YURI A BLEDNOV, ROBERT O. MESSING · 2001 to 2026
$9.5M
BRAIN MEMBRANES IN ALCOHOL AND BENZODIAZEPINE DEPENDENCER01AA006399 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI HARRIS, ROBERT A · 1985 to 2018
$8.8M
NIAAA NIH HHS AA U01 13520NIAAA NIH HHS R01 AA006399NIAAA NIH HHS U01 AA013520PHS HHS A06399
6 · The paper itself

Abstract

Recent studies have demonstrated that metabotropic glutamate receptor 5 (mGluR5) antagonists decrease alcohol self-administration and suggest that the anti-craving medication, acamprosate, may also act to decrease mGluR5 function. To address the role of mGluR5 in behavioural actions of ethanol and acamprosate, we compared mutant mice with deletion of the mGluR5 gene and mice treated with a mGluR5 antagonist (MPEP) or acamprosate. Lack of mGluR5 or administration of MPEP reduced the severity of alcohol-induced withdrawal (AW), increased the sedative effect of alcohol (duration of loss of righting reflex; LORR), and increased basal motor activity. The motor stimulation produced by ethanol was blocked by deletion of mGluR5, but not by injection of MPEP. Both acamprosate and MPEP increased ethanol-induced LORR and reduced AW. Importantly, the protective effects of both MPEP and acamprosate on AW were found when the drugs were injected before, but not after, injection of ethanol. This indicates that the drugs prevented development of dependence rather than merely producing an anticonvulsant action. No effects of acamprosate or MPEP on ethanol-induced LORR and AW were found in mGluR5 knockout mice, demonstrating that mGluR5 is required for these actions. mGluR5 null mutant mice showed decreased alcohol consumption in some, but not all, tests. These data show the importance of mGluR5 for several actions of alcohol and support the hypothesis that some effects of acamprosate require mGluR5 signalling.

Indexed as

AcamprosateAlcohol DeterrentsAlcohol DrinkingAlcoholismAnalysis of VarianceAnimalsBehavior, AnimalCentral Nervous System DepressantsChoice BehaviorConditioning, OperantDose-Response Relationship, DrugDrug InteractionsEthanolExcitatory Amino Acid AntagonistsFemaleMale6-methyl-2-(phenylethynyl)pyridineAcamprosateAlcohol DeterrentsCentral Nervous System DepressantsEthanolExcitatory Amino Acid AntagonistsGrm5 protein, mousePyridinesReceptor, Metabotropic Glutamate 5Receptors, Metabotropic GlutamateTaurine

Identifiers

PMID18377703
PMCPMC2574715
OpenAlexW2099858791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.